Strip of 10 Units
Old MRP ₹44
MRP ₹41.25
₹20.58
₹4.12/Units
Use current location
Login to view saved addresses
100% genuine medicines
Safe & secure payments
15 days Easy returns
Prescription required for this medicine
Store Below 30o C
CompositionVertiford-8 Tablet is used in managing Ménière’s disease, a condition affecting the inner ear and causing vertigo, dizziness, and balance problems.
It is also used in reducing vertigo attacks, tinnitus, and hearing loss associated with this disorder. Take it as advised by your doctor and share any medical history or ongoing treatments. Report side effects immediately and continue the medicine for the entire prescribed duration.
Vertiford-8 Tablet is used to treat vertigo, dizziness, and balance problems caused by inner ear disorders such as Ménière’s disease. It helps reduce spinning sensations, nausea, and ringing in the ears, improving stability and daily functioning.
Ensure you use Vertiford-8 Tablet correctly with these steps:
Swallow the tablet whole with a glass of water.
Avoid breaking, crushing, or chewing the tablet.
Remember to take this medicine at regular intervals as advised by your doctor.
It's crucial not to abruptly stop taking this medicine without consulting your doctor.
Seek your doctor's advice for a dosage schedule that suits your health condition.
Vertiford-8 Tablet is taken orally.
Vertiford-8 Tablet may cause side effects such as nausea, stomach discomfort, vomiting, headache, dizziness, rash, and excessive sleepiness. If these side effects worsen or persist, consult your doctor.
Most side effects are temporary and generally harmless, which resolve on discontinuing the use of Vertiford-8 Tablet. However, if you experience any serious side effects or worsening of any of the symptoms, please consult your doctor.
Here are some general guidelines for managing common side effects:
Gastrointestinal disturbances: To manage symptoms such as nausea or dyspepsia caused by Vertiford-8 Tablet, try taking this medicine with meals.
Dizziness: When using Vertiford-8 Tablet, if you experience dizziness during the day, consider taking this medicine at bedtime.
Vertiford-8 Tablet contains betahistine (8 mg), which works on the body as follows:
Increases Blood Flow: Betahistine has vasodilatory effects, meaning it widens blood vessels. This increases blood flow to the inner ear, helping reduce pressure and regulate fluid balance in the labyrinth of the ear.
Enhances Histamine Release: By blocking H3 receptors in the inner ear, betahistine increases histamine release. This enhances circulation in the inner ear.
Suppresses Vertigo Signals: Betahistine stimulates the vestibular nuclei in the brainstem directly. This stimulation may help suppress signals that cause vertigo.
Vertiford-8 Tablet is contraindicated during pregnancy. If you are pregnant or planning to conceive, make sure to discuss this with your doctor before starting this medicine.
Vertiford-8 Tablet is contraindicated for breastfeeding/lactating women. Consult your doctor to understand the potential risks and benefits.
There's no specific information about the interaction of Vertiford-8 Tablet and alcohol. Caution is advised while consuming alcohol during the course of this medication. It would be wise to consult your doctor on this matter.
Caution is advised while taking Vertiford-8 Tablet in case of mild to moderate liver impairment. This medicine may affect liver function. If you have liver problems, discuss them with your doctor before starting Vertiford-8 Tablet.
Caution is advised before using Vertiford-8 Tablet if you have a history of any kidney problems. It's a good idea to consult your doctor before starting this medication.
As vertigo is one of the symptoms managed by Vertiford-8 Tablet, caution should be exercised while driving or operating heavy machinery until you know how the medicine affects you.
If you have a known hypersensitivity to betahistine or any other excipients in the tablet, do not take Vertiford-8 Tablet. Always inform your doctor about any allergies before starting a new medicine.
Caution is advised while giving Vertiford-8 Tablet to children under 18 years of age. Always consult your doctor before giving this medicine to a child.
Older patients should take Vertiford-8 Tablet under medical supervision as they may be more susceptible to its side effects. Your doctor will guide you based on your health status.
Vertiford-8 Tablet interacts with the following medicines:
Antihistamines: Medicines like diphenhydramine might reduce the efficacy of Vertiford-8 Tablet by opposing its action at histamine receptors.
H2 Receptor Antagonists: Medications such as ranitidine can decrease the absorption of betahistine, the active ingredient in Vertiford-8 Tablet.
Cholinergic and Anticholinergic Drugs: These medicines might have their effects potentiated by Vertiford-8 Tablet.
Monoamine Oxidase Inhibitors (MAOIs): These drugs may enhance the side effects of betahistine in Vertiford-8 Tablet.
No specific food interactions have been identified with Vertiford-8 Tablet.
Vertiford-8 Tablet interacts with the following diseases:
Pheochromocytoma: This medicine should not be used by patients with this condition as it may cause a hypertensive crisis.
Peptic Ulcer Disease: Betahistine in Vertiford-8 Tablet can increase gastric acid secretion, which could worsen peptic ulcers.
Bronchial Asthma: The active ingredient betahistine may exacerbate bronchoconstriction, so patients with asthma should use this medicine cautiously.
Severe Renal or Hepatic Impairment: As betahistine is extensively metabolised and excreted, patients with severe renal or hepatic impairment should take caution when using the Vertiford-8 Tablet.
The daily dose of Vertiford-8 Tablet should be taken as per your doctor's prescription. The dosage can vary based on individual factors such as the severity of your condition and how well you respond to the medicine. Always adhere to the prescribed dosage and don't exceed it without consulting your doctor.
If you happen to take more than the prescribed dose of Vertiford-8 Tablet, you may experience symptoms such as severe stomach upset, dizziness, and confusion. Should these symptoms persist or get worse, contact your doctor.
If you've missed a dose of Vertiford-8 Tablet, take it as soon as you remember. However, if your next dose is nearly due, skip the missed one and continue with your regular schedule. Don't increase your dose without your doctor's advice.
As Vertiford-8 Tablet is used to manage Ménière's disease, reducing your salt intake can help lessen fluid build-up in your inner ear, potentially improving your symptoms.
Regular light exercise, like walking or yoga, can help improve your balance and reduce vertigo episodes, complementing the action of Vertiford-8 Tablet.
| Available Dosage Types | Tablet |
| Habit Forming | No |
| Ailment | Ménière's Disease, Vertigo |
| Drug Category | Histamine Analog |
| Therapeutic Category | Antivertigo |
This medicine is used primarily to manage symptoms of Ménière's disease, which includes vertigo (spinning sensation), tinnitus (ear ringing), and hearing loss.
It works by increasing blood flow to the inner ear, reducing pressure, and regulating fluid balance. It also blocks certain receptors to enhance circulation.
The medication is specifically indicated for Ménière's disease. For any other condition, consult with your doctor first.
If you have a known allergy to betahistine or any other ingredient in the tablet, avoid taking Vertiford-8 Tablet.
Yes, common side effects include nausea, headaches, skin rash. Dizziness and somnolence might also occur but are usually mild and transient.
Certain medicines may interact with Vertiford-8 Tablet. Always inform your doctor about all the medicines you are currently taking.
Store the medicine in a cool and dry place, protected from light and moisture, and out of reach of children.
Check out Editorial Policy
National Health Service. (2021). Betahistine. https://www.nhs.uk/medicines/betahistine/. Accessed 1 April 2024.
DrugBank. (2021). Betahistine. https://go.drugbank.com/salts/DBSALT002969. Accessed 1 April 2024.
Magnan, J., Özgirgin, O. N., Trabalzini, F., Lacour, M., Escamez, A. L., Magnusson, M., Güneri, E. A., Guyot, J. P., Nuti, D., & Mandalà, M. (2018). European Position Statement on Diagnosis, and Treatment of Meniere's Disease. The journal of international advanced otology, 14(2), 317–321. https://doi.org/10.5152/iao.2018.140818
We, at Truemeds make a diligent attempt to deliver accurate, expert- drafted and thoroughly reviewed medicine related information to our consumers. However, it should, by no means, be considered a substitute for prescription from a certified doctor or a trustworthy doctor-patient relationship. In fact we detest any form of self medication without expert advice. The sole purpose of the information on our portal is to educate our consumers, which helps improve the communication between a doctor and a patient. The information by no means is complete in its entirety and should not be used to diagnose or treat any medical condition. No amount of information can replace the experience and expertise of a doctor, therefore his/her advice always holds priority and should be followed appropriately.
...View more
...View more
...View more
Company
About UsHealth ArticleHealth StoriesHealth LibraryDiseases & Health ConditionsAyurvedaUnderstanding Generic MedicinesAll MedicinesAll BrandsNeed HelpFAQSecuritySavings CalculatorSubscribe
Registered Office Address
Grievance Officer
Download Truemeds
Contact Us
Our customer representative team is available 7 days a week from 9 am - 9 pm.
v4.14.0
2026 - Truemeds | All rights reserved. Our content is for informational purposes only. See additional information.
Our Payment Partners
